Physiology, Vasodilation

Article Author:
Riddhi Ramanlal
Article Editor:
Vikas Gupta
Updated:
5/21/2020 11:54:07 PM
For CME on this topic:
Physiology, Vasodilation CME
PubMed Link:
Physiology, Vasodilation

Introduction

Vasodilation is the widening of blood vessels as a result of the relaxation of the blood vessel muscular walls. Vasodilation is a mechanism to enhance blood flow to areas of the body that are lacking oxygen and/or nutrients. The vasodilation causes a decrease in systemic vascular resistance (SVR) and an increase in blood flow, resulting in a reduction of blood pressure. 

Issues of Concern

Although vasodilation is a natural response necessary for our bodies, in specific scenarios, excessive vasodilation can cause harm:

Anaphylaxis

Severe anaphylactic shock occurs when a rapid release of inflammatory mediators and cytokines trigger widespread vasodilation and increased vascular permeability. This situation leads to the activation of the inflammatory cascade, and immediate epinephrine is the first-line treatment.[1]

Septic Shock

Vasodilation is a normal response that occurs during inflammatory processes to increase blood flow to affected areas. However, in response to overwhelming infection, our bodies release numerous vasodilatory chemicals that cause inflammation and can lead to lethal hypotension.[2]

Cellular

Endothelial cells form the lining of blood vessels. These cells have the critical ability to rearrange to remodel the vasculature network. This feature of endothelial cells enables blood vessel changes and adequate blood flow to allow tissue growth and repair throughout the body. The endothelial cells are closest to the lumen of both arteries and veins. Surrounding the thin endothelial cell layer is a basal lamina, followed by varying amounts of smooth muscle cells and connective tissue dependent on the vessel’s function. In contrast to arteries and veins, capillaries are only a single layer of endothelial cells and pericytes.[3]

Development

Arteries and veins develop from initially small vessels composed of endothelial cells. The remaining components of the blood vessel lining are subsequently added upon signaling from the endothelial cells. Endothelial cells have mechanoreceptors that can sense stress. These allow the endothelial cells to signal the surrounding cells to produce adaptations of the connective tissue and smooth muscle to decrease stress and better accommodate the blood flow. If an area of the vascular system is damaged, the endothelial cells can undergo cell division and proliferate to repair areas. 

Angiogenesis is the process of new blood vessel formation. It occurs as a response to signaling from endothelial cells in an existing blood vessel. The most notable signals are vascular endothelial growth factor (VEGF) and fibroblast growth factor family (FGF).[4] 

Organ Systems Involved

All organ systems in the body are affected by vasodilation. Vasodilation increases blood flow to tissues throughout the body.

Function

The purpose of vasodilation is to increase blood flow to the tissues in the body. In response to a need for oxygen or nutrients, tissues can release endogenous vasodilators. The result is a decrease in vascular resistance and an increase in capillary perfusion. A common example of this vasodilation response occurs during exercise. When exercising, the oxygen consumption by skeletal muscles rapidly increases, and it is necessary to, therefore, increase the oxygen supply.

Mechanism

Vasodilation occurs when the smooth muscle located in the blood vessel walls relax. Relaxation can be due to either removal of a contractile stimulus or inhibition of contractility. Numerous stimuli, including acetylcholine, ATP, adenosine, bradykinin, histamine, and shear stress, can activate eNOS and COX pathways that form nitric oxide (NO) and prostacyclin, respectively. NO and prostacyclin produced within endothelial cells utilizes intracellular secondary messengers. NO primarily uses cyclic guanosine monophosphate (cGMP) for cellular effects, whereas prostacyclin effects are primarily mediated by cyclic adenosine monophosphate (cAMP).[5] These secondary messengers produced in the smooth muscle cells have downstream effects of causing a decrease in intracellular Ca and an increase in myosin light chain (MLC) phosphatase activity. In smooth muscle cells, active MLC phosphatase dephosphorylates the contracted actin and MLC complex, causing MLC to relax. Intracellular cations are removed by Ca, Mg-ATPases that sequester Ca back into the sarcoplasmic reticulum. Additionally, Na/Ca antiporters located in the plasma membrane can decrease intracellular Ca. During relaxation, receptor-gated and voltage-gated Ca channels inhibit Ca entry into the smooth muscle cell.[6] The overall effect is the relaxation of the smooth muscle, which causes vasodilation. 

Other mediators involved in vasodilation are generated during enhanced muscle activity. These stimuli include pCO, lactate, K, and adenosine. Venous pCO levels increase during exercise due to the high turnover of the Krebs cycle to meet the oxygen demands of skeletal muscle. There is a net gain in lactic acid produced by exercising muscle due to increased glycolysis activity. Skeletal muscle cells release K ions into the interstitium during an action potential. During exercise, there is also an increase in the breakdown of adenosine triphosphate (ATP), yielding adenosine. These above mediators produced can diffuse to adjacent arterioles and have powerful vasodilatory effects to increase the oxygen and nutrient supply to exercising muscle when demand is enhanced.[7]

Related Testing

Myocardial perfusion testing is a noninvasive diagnostic evaluation performed on patients with suspected coronary artery disease. Pharmacological stimuli, most commonly adenosine, are used to assess myocardial blood flow and coronary flow reserve. Adenosine is a powerful vasodilator used in these tests to produce maximal hyperemia during the imaging.[8]

Acute vasodilator testing can help to identify patients with pulmonary artery hypertension (PAH) who may respond to calcium channel blocker therapy. The testing procedure is performed during a right-heart catheterization. Vasodilatory medications are administered to assess the ability of the pulmonary arteries to relax before and after administration. Commonly used vasodilator drugs for the procedure include nitric oxide, epoprostenol, and adenosine.[9]

Pathophysiology

While multiple different mechanisms can contribute to shock, one of the most common is a distributive shock. Distributive shock characteristically demonstrates widespread peripheral vasodilation caused by loss of vascular smooth muscle reactivity.[10] The vasodilation causes hypotension with resulting tissue hypoperfusion. Patients with septic shock, a type of distributive shock, often have elevated levels of catecholamines. The catecholamines are released by the body as endogenous vasoconstrictors but are unable to elicit an appropriate pressor response in the pathologic shock state. Additionally, endothelial cells can overexpress nitric oxide, contributing to even more pronounced vasodilation.[11] Management of this vasodilatory shock requires fluid resuscitation and the initiation of norepinephrine, a potent vasopressor. If this therapy is refractory, other vasopressors such as vasopressin and epinephrine can be added.[2]

Clinical Significance

Hypertension is the term for elevated blood pressure. More specifically, a systolic blood pressure ≥130 mmHg and/or a diastolic pressure ≥ 80 mmHg. Numerous medication classes are in clinical use to reduce high blood pressures by promoting vasodilation: 

  • Calcium Channel Blockers (CCBs): Block Ca+2 ions influx into vascular smooth muscle and cardiac muscle. The inhibition of Ca+2 leads to the relaxation of the vascular muscle cells and, therefore, vasodilation. These are primarily used to treat hypertension and angina.[12]
  • Nitrates: Utilizes secondary messengers that cause downstream effects of smooth muscle relaxation. Nitroglycerine is a nitrate most commonly used to relieve angina attacks.[13]
  • Angiotensin-Converting Enzyme (ACE) Inhibitors: Prevent the production of angiotensin II and inhibit the breakdown of bradykinin. Angiotensin II normally decreases NO production, and bradykinin stimulates the release of NO. The combined effects of this lead to increased NO, which causes vasodilation and can be used to lower blood pressure.[14]

References

[1] KrĨmová I,Novosad J, Anaphylactic symptoms and anaphylactic shock. Vnitrni lekarstvi. 2019 Winter;     [PubMed PMID: 30909706]
[2] Jentzer JC,Vallabhajosyula S,Khanna AK,Chawla LS,Busse LW,Kashani KB, Management of Refractory Vasodilatory Shock. Chest. 2018 Aug;     [PubMed PMID: 29329694]
[3] Krüger-Genge A,Blocki A,Franke RP,Jung F, Vascular Endothelial Cell Biology: An Update. International journal of molecular sciences. 2019 Sep 7;     [PubMed PMID: 31500313]
[4] Boulanger CM, Endothelium. Arteriosclerosis, thrombosis, and vascular biology. 2016 Apr;     [PubMed PMID: 27010027]
[5] Hellsten Y,Nyberg M,Jensen LG,Mortensen SP, Vasodilator interactions in skeletal muscle blood flow regulation. The Journal of physiology. 2012 Dec 15;     [PubMed PMID: 22988140]
[6] Webb RC, Smooth muscle contraction and relaxation. Advances in physiology education. 2003 Dec;     [PubMed PMID: 14627618]
[7] Sarelius I,Pohl U, Control of muscle blood flow during exercise: local factors and integrative mechanisms. Acta physiologica (Oxford, England). 2010 Aug;     [PubMed PMID: 20353492]
[8] Knaapen P, Optimal Vasodilation Protocols: The Devil Is in the Details. Circulation. Cardiovascular imaging. 2017 Feb;     [PubMed PMID: 28213450]
[9] Sharma A,Obiagwu C,Mezue K,Garg A,Mukherjee D,Haythe J,Shetty V,Einstein AJ, Role of Vasodilator Testing in Pulmonary Hypertension. Progress in cardiovascular diseases. 2016 Jan-Feb;     [PubMed PMID: 26434988]
[10] Vincent JL,De Backer D, Circulatory shock. The New England journal of medicine. 2013 Oct 31;     [PubMed PMID: 24171518]
[11] Russell JA,Rush B,Boyd J, Pathophysiology of Septic Shock. Critical care clinics. 2018 Jan;     [PubMed PMID: 29149941]
[12] Calcium Channel Blockers 2012;     [PubMed PMID: 31643892]
[13] Tarkin JM,Kaski JC, Vasodilator Therapy: Nitrates and Nicorandil. Cardiovascular drugs and therapy. 2016 Aug;     [PubMed PMID: 27311574]
[14] Ancion A,Tridetti J,Nguyen Trung ML,Oury C,Lancellotti P, A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril. Cardiology and therapy. 2019 Dec;     [PubMed PMID: 31578675]